Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded Ignite Restaurant Group (NASDAQ: IRG) from Overweight to Neutral. The target price for Ignite Restaurant Group has been lowered from $14.00 to $8.00. Ignite Restaurant Group's shares closed at $8.13 yesterday.

Wedbush downgraded Calavo Growers (NASDAQ: CVGW) from Outperform to Neutral. The target price for Calavo Growers is set to $39. Calavo Growers' shares closed at $39.13 yesterday.

Analysts at Baird downgraded OmniVision Technologies (NASDAQ: OVTI) from Outperform to Neutral. The target price for OmniVision Technologies is set to $27. OmniVision Technologies' shares closed at $28.29 yesterday.

DA Davidson downgraded Ducommun (NYSE: DCO) from Buy to Neutral. The target price for Ducommun has been raised from $28.00 to $34.00. Ducommun's shares closed at $31.60 yesterday.

Latest Ratings for IRG

DateFirmActionFromTo
Aug 2015DowngradesNeutralSell
May 2015
May 2015DowngradesNeutralUnderweight

View More Analyst Ratings for IRG
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CVGW + DCO)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
EBAYMaintains34.5
WDCReiterates60.0
WATMaintains230.0
WRBMaintains56.0
MRVLMaintains29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Avion Pharma Reports Signing of Commercial License Deal with Ligand Pharma for Development, Commercialization of Four Captisol-Enabled Programs, Ligand Entitled to Upfront Payment

Baltic Dry Index Rallies 30 Percent; Stocks Respond